MSI Financial Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$61K Hold
423
﹤0.01% 1760
2016
Q3
$50K Sell
423
-336
-44% -$40.4K ﹤0.01% 1832
2016
Q2
$80K Buy
759
+190
+33% +$21.2K ﹤0.01% 1537
2016
Q1
$63K Buy
569
+136
+31% +$17.2K ﹤0.01% 1604
2015
Q4
$68K Buy
433
+224
+107% +$32.6K ﹤0.01% 1519
2015
Q3
$27K Buy
209
+26
+14% +$4.17K ﹤0.01% 1557
2015
Q2
$32K Sell
183
-77
-30% -$13.9K ﹤0.01% 1553
2015
Q1
$45K Buy
260
+163
+168% +$24.9K ﹤0.01% 1369
2014
Q4
$13K Hold
97
﹤0.01% 1711
2014
Q3
$12K Sell
97
-801
-89% -$82.6K ﹤0.01% 1745
2014
Q2
$79K Hold
898
0.01% 896
2014
Q1
$84K Buy
898
+768
+591% +$78.5K 0.01% 825
2013
Q4
$15K Buy
130
+103
+381% +$9.29K ﹤0.01% 1523
2013
Q3
$2K Sell
27
-1,032
-97% -$75.4K ﹤0.01% 1982
2013
Q2
$70K Buy
+1,059
New +$68.2K 0.01% 756

Other funds holding UTHR

MSI Financial Services's UTHR Position: Q4 2016 in Review

MSI Financial Services held its United Therapeutics (UTHR) position steady in Q4 2016 at 423 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

MSI Financial Services first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $84K in Q1 2014. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • MSI Financial Services held 423 shares of United Therapeutics worth $61K as of Q4 2016.
  • MSI Financial Services left its United Therapeutics share count unchanged in Q4 2016.
  • United Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1760 holding.
  • MSI Financial Services first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's United Therapeutics position peaked at $84K in Q1 2014.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.